DTC

Deep Track Capital Portfolio holdings

AUM $3.11B
This Quarter Return
-9.81%
1 Year Return
+13.6%
3 Year Return
+265.73%
5 Year Return
–
10 Year Return
–
AUM
$1.55B
AUM Growth
+$1.55B
Cap. Flow
+$361M
Cap. Flow %
23.32%
Top 10 Hldgs %
50.82%
Holding
63
New
11
Increased
28
Reduced
8
Closed
11

Top Buys

1
ALNY icon
Alnylam Pharmaceuticals
ALNY
$75.7M
2
FATE icon
Fate Therapeutics
FATE
$61.3M
3
NVCR icon
NovoCure
NVCR
$37.3M
4
AGEN
Agenus
AGEN
$34.4M
5
BCYC
Bicycle Therapeutics
BCYC
$33.2M

Top Sells

1
RNA icon
Avidity Biosciences
RNA
$23.8M
2
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
$17.1M
3
PTGX icon
Protagonist Therapeutics
PTGX
$14.4M
4
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
$13.2M
5
ATRA icon
Atara Biotherapeutics
ATRA
$11.8M

Sector Composition

1 Healthcare 99.98%
2 Real Estate 0.02%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ASND icon
51
Ascendis Pharma
ASND
$11.8B
– –
-80,000
Closed -$10.8M
ATRA icon
52
Atara Biotherapeutics
ATRA
$84.6M
– –
-750,000
Closed -$11.8M
BBIO icon
53
BridgeBio Pharma
BBIO
$9.89B
– –
0
– –
CNTA
54
Centessa Pharmaceuticals
CNTA
$2.25B
– –
-400,000
Closed -$4.5M
CNTB
55
Connect Biopharma
CNTB
$115M
– –
-647,057
Closed -$3.33M
NKTR icon
56
Nektar Therapeutics
NKTR
$568M
– –
0
– –
PTGX icon
57
Protagonist Therapeutics
PTGX
$3.67B
– –
-421,660
Closed -$14.4M
RNA icon
58
Avidity Biosciences
RNA
$5.99B
– –
-1,000,000
Closed -$23.8M
VNDA icon
59
Vanda Pharmaceuticals
VNDA
$279M
– –
-500,000
Closed -$7.85M
TECX
60
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
– –
-1,050,132
Closed -$4.04M
KRTX
61
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-130,200
Closed -$17.1M
ONCR
62
DELISTED
Oncorus, Inc.
ONCR
– –
-600,000
Closed -$3.16M
SRRA
63
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-607,600
Closed -$13.2M
1 2
3